Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |